

TRADING UPDATES: Synectics loss narrows; Active Energy loss widens


(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced new preclinical data on Monday, which showed 'SFX-01' could be of be...


IN BRIEF: Evgen Pharma appoints Huw Jones as chief medical officer


IN BRIEF: Evgen Pharma notes publication on sulforaphane in Covid-19


IN BRIEF: Evgen Pharma names Helen Kuhlman as chief business officer


(Sharecast News) - Clinical-stage drug development company Evgen announced on Monday that Helen Kuhlman had been appointed to the post of chief busine...


IN BRIEF: Evgen says no patient safety concerns in STAR Covid-19 trial


(Sharecast News) - Clinical stage drug development company Evgen Pharma announced on Thursday that after a review of the first 60 patients enrolled, t...